Analyst stock forecast
Denali Therapeutics Stock Forecast and Analyst Price Target
DNLI analyst target range, upside, consensus rating and coverage count.
Direct answer
Denali Therapeutics's average price target is $34.31.
The target implies +42% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $25.00 to $42.00, with 16 analysts in the current consensus when available.
Forecast evidence checked August 5, 2026.
Verified data
- Current price
- $24.17
- Average price target
- $34.31
- High price target
- $42.00
- Low price target
- $25.00
- Target upside
- +42%
- Consensus rating
- Strong Buy
- Analysts
- 16
- Evidence date
- August 5, 2026
- Valid through
- August 12, 2026